secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001326110-24-000069
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio annual meeting: directors re-elected, equity plan shares increased by 19.9M
--------------------------------------------------------------------------------

- All nine director nominees re-elected, including Patrick Soon-Shiong, with over 556M votes For each.
- Amendment to increase authorized shares under 2015 Equity Incentive Plan by 19.9M shares approved (547M For).
- Say-on-pay advisory vote approved with 556.7M For votes.
- Ratification of Ernst & Young as auditor for FY2024 ratified (606.9M For).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000132611024000069/0001326110-24-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000132611024000069/ibrx-20240611.htm
  HTML page:      https://secwatch.observer/filing/0001326110-24-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer